UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
When will NOAC reversal agents be available in Korea?
Several drugs that reverse the blood thinning effect of non-vitamin K oral ...
by Kim Yun-mi
|
2019-03-07 15:52
라인
Off-label use of sirolimus for pediatric pulmonary vein stenosis banned
The government has banned the off-label use of sirolimus, an immunosuppress...
by Lee Hye-seon
|
2019-03-07 15:10
라인
Amgen’s Xgeva solves adverse effect problems
Amgen’s Xgeva (ingredient: denosumab) has resolved adverse effect issues fo...
by Lee Han-soo
|
2019-03-07 14:25
라인
‘Korean drugmakers can tap US generic market’
Korean pharmaceutical companies would find it better to utilize long-accumu...
by Jeong Sae-im
|
2019-03-07 11:54
라인
Chinese partner to start trials for Genexine’s immunotherapeutic drug candidate
Genexine said Monday that I-Mab Biopharma, a Chinese bio-firm, has administ...
by Lee Han-soo
|
2019-03-06 14:27
라인
Binex, Chongqing Zein to establish joint company
Binex said Wednesday that it has signed an agreement to establish a joint-v...
by Lee Han-soo
|
2019-03-06 13:41
라인
Medytox keeps urging Daewoong to clarify suspicions over BTX’s origin
Medytox continued Tuesday to pressure Daewoong Pharmaceuticals to clarify s...
by Lee Han-soo
|
2019-03-05 16:22
라인
Hanmi’s acute myeloid leukemia wins developmental stage orphan drug status
The Ministry of Food and Drug Safety has granted Hanmi’s HM43239, a treatme...
by Lee Han-soo
|
2019-03-05 15:34
라인
Handok to market Amicus Therapeutics’ Fabry disease treatment
Handok said Tuesday that it has signed a local sales agreement with Amicus ...
by Lee Han-soo
|
2019-03-05 15:11
라인
Lilly Korea to test rheumatoid arthritis drug for hair loss treatment
Lilly Korea is to conduct a clinical trial on rheumatoid arthritis drug Olu...
by Lee Hye-seon
|
2019-03-05 15:10
라인
3rd-generation antiepileptic drug lands on Korea
Briviact(ingredient: brivaracetam), a third-generation antiepileptic treatm...
by Lee Hye-seon
|
2019-03-05 14:42
라인
IVI gets $3.2 million for typhoid conjugate vaccine study in W. Africa
The International Vaccine Institute (IVI) said it has received a $3.2 milli...
by Lee Han-soo
|
2019-03-05 14:41
라인
Hanmi releases P4 clinical trials for anti-hypertension treatment
Hanmi Pharmaceutical said Monday that it has published the results of phase...
by Lee Han-soo
|
2019-03-04 17:01
라인
Regulator expands XGEVA’s indication for use by multiple myeloma patients
Amgen’s XGEVA (denosumab), a treatment for reducing possibilities of skelet...
by Kim Yun-mi
|
2019-03-04 16:02
라인
AbbVie gets positive views for treatment of plaque psoriasis in EU
AbbVie said Monday that the European Medicines Agency's Committee for M...
by Lee Han-soo
|
2019-03-04 15:57
라인
Qurient unveils P2a trial results for atopic dermatitis treatment in US
Qurient said Monday that it has presented the phase 2a clinical trial resul...
by Lee Han-soo
|
2019-03-04 14:16
라인
US trade agency begins probe into Medytox’s complaint about Daewoong
Medytox said Monday that the U.S. International Trade Commission has starte...
by Lee Han-soo
|
2019-03-04 11:16
라인
GC starts P1 trials of hemophilia treatment
GC said Thursday that it has administered the first dose of MG1113, a hemop...
by Lee Han-soo
|
2019-02-28 16:45
라인
Bukwang to sell Novartis’ chronic hepatitis B treatment
Bukwang Pharmaceutical said Thursday that it has just begun domestic market...
by Lee Han-soo
|
2019-02-28 14:59
라인
Chong Kun Dang topped clinical trials in 2018
Local drugmaker Chong Kun Dang won approval for clinical trials the most am...
by Lee Hye-seon
|
2019-02-28 10:50
-
이전
51
52
53
54
55
56
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top